Search Ontology:
ChEBI
zipalertinib
- Term ID
- CHEBI:233402
- Synonyms
-
- (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido(5,4-b)indolizin-8-yl)acrylamide
- CLN 081
- CLN-081
- CLN081
- N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
- TAS 6417
- TAS-6417
- TAS6417
- TPC 064
- TPC-064
- TPC064
- zipalertinib
- zipalertinibum
- Definition
- A member of the class of acrylamides that is (8S)-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizine-4,8-diamine in which the amino group at position 8S is substituted by an acryloyl group. It a covalent epidermal growth factor receptor inhibitor that targets exon 20 insertion mutations.
- References
-
- cas:1661854-97-2
- drugbank:DB18763
- pdb-ccd:X9H
- pubmed:29748209
- pubmed:31467113
- pubmed:36324498
- pubmed:36380577
- pubmed:36915628
- pubmed:37384848
- pubmed:37487151
- pubmed:37669428
- pubmed:38229766
- pubmed:38770784
- pubmed:39417568
- pubmed:39471218
- wikipedia.en:Zipalertinib
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from zipalertinib
Phenotype where environments contain zipalertinib
Phenotype modified by environments containing zipalertinib
Phenotype affecting zipalertinib
Human Disease Model